Dr John H Whiting Jr, MD | |
444 Hospital Way, Suite 701, Pocatello, ID 83201-2701 | |
(208) 233-7931 | |
(208) 233-0423 |
Full Name | Dr John H Whiting Jr |
---|---|
Gender | Male |
Speciality | Radiology - Vascular & Interventional Radiology |
Location | 444 Hospital Way, Pocatello, Idaho |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316913254 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0204X | Radiology - Vascular & Interventional Radiology | M-8625 (Idaho) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr John H Whiting Jr, MD 444 Hospital Way, Suite 701, Pocatello, ID 83201-2701 Ph: (208) 233-7931 | Dr John H Whiting Jr, MD 444 Hospital Way, Suite 701, Pocatello, ID 83201-2701 Ph: (208) 233-7931 |
News Archive
Health risks are real and ever-changing, especially while traveling abroad. The bird flu, for example, has been in the news recently for taking four more lives, bringing the total deaths to 31.
World class scientist Professor Willem M. de Vos will explain next Monday how the microbes that are closest to our hearts - gut microbes - could underpin a new way of thinking about human biology. As well as looking at our own genes, we can now include those of our microbes in studies of human health and disease. This is a significant shift in the way we approach human biology.
Men with prostate cancer face tough choices: when, or even if, to treat their cancer; what procedure to use; and how to balance their chosen treatment with their quality of life. Now, a new multicenter clinical trial seeks to offer men another option - one that physicians hope will treat prostate cancers with fewer side effects.
Innovent Oncology, a subsidiary of US Oncology, has engaged Milliman, a premier global, actuarial and consulting firm, to help develop models in which physician-led oncology organizations can contract around risk, with the intent of negotiating with payers in the first half of 2011.
The investigational drug alirocumab significantly improved cholesterol levels compared to ezetimibe, when added to regular statin therapy in patients with high cholesterol and elevated risk of cardiovascular disease (CVD), according to the ODYSSEY COMBO II trial, presented as a Hot Line today at ESC Congress 2014.
› Verified 1 days ago
Artur Narkiewicz-jodko, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 777 Hospital Way, Pocatello, ID 83201 Phone: 208-239-1000 | |
Dr. Allen A. Eng, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1151 Hospital Way, Bldg B, Pocatello, ID 83201 Phone: 208-233-1187 Fax: 208-233-1187 | |
Dr. Lorin C Bachman, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 777 Hospital Way, Pocatello, ID 83201 Phone: 208-239-1000 | |
Jade Forbush, RDMS Radiology Medicare: Not Enrolled in Medicare Practice Location: 1334 N Main St, Pocatello, ID 83204 Phone: 208-539-7399 Fax: 208-417-0882 | |
Dr. Michael T. Callaghan, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 500 S 11th Ave, Suite 101, Pocatello, ID 83201 Phone: 208-239-1750 Fax: 208-239-1771 | |
Mr. Nicholas S Pierson, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 777 Hospital Way, Pocatello, ID 83201 Phone: 208-239-1000 |